Recently, our CEO and Founder Baroness Susan Greenfield sat with Tom Froggatt and discussed, among many other things, what makes Neuro-Bio Ltd different and why our approaches are so novel. Susan was a guest on Careers in Discovery, with Tom Froggatt and they explored...
NEURO-BIO LTD HAS BEEN GRANTED A TECNIOSPRING INDUSTRY AWARD 2021 Neuro-Bio has been awarded a Tecniospring INDUSTRY award together with the Catalan CRO, Xenopat (www.xenopat.com ) to develop a new antitumor drug and / or antimetastatic drug based on the inhibition of...
We are delighted to announce Rosie and James have accepted their offers to continue their work with Neuro-Bio for 3 more months! Here’s their thoughts about the extension: “I am thrilled to have extended my time at Neuro-Bio for an extra three months! I...
Neuro-bio announces a collaboration with Professor Zoltán Molnár and Auguste Vadisiute. Auguste is a DPhil student at Christ Church College at the University of Oxford (Department of Physiology, Anatomy and Genetics) and is studying the role of microglia in...
ENDORSEMENT FROM THE UK REGULATORY BODY (MEDICINES & HEALTHCARE PRODUCTS REGULATORY AGENCY, MHRA) Neuro-Bio has just been awarded a ‘Passport of Innovation’ from the MHRA. The company is very much at the forefront of this new concept of ‘Innovation Licensing and...
